Imidafenacin 170105-16-5 is a new type of diphenylbutanamide anticholinergic drugs, with a high degree of bladder selectivity for overactive bladder. Bladder hyperactivity is a sign of urgency characterized by frequent urination and nocturia, with or without urge incontinence. Detrusor instability is one of the important causes of overactive bladder. Detrusor muscle has the distribution of the M receptor, so detrusor contraction control by choline. Imazapril has the effect of diphenylbutanamide, which blocks the contraction of the detrusor and inhibits detrusor relaxation. Taking Imidafenacin can significantly improve urinary frequency, urinary incontinence and other symptoms. it also has a role in inhibiting bladder smooth muscle contraction and inhibition of acetylcholine free dual effects, and the selectivity of the bladder is stronger than the salivary glands.

Thera. Category: Anticholinergic

Cas No.:170105-16-5

Synonym:ONO 8025;Staybla;Uritos;1H-IMidazole-1-butanaMide,2-Methyl-a,a-diphenyl-;4-(2-METHYL-1H-IMIDAZOL-1-YL)-2,2-DIPHENYLBUTANAMIDE;Imidafenacin;2-Methyl-α,α-diphenyl-1H-iMidazole-1-butanaMide;4-(2-Methyl-1-iMidazolyl)-2,2- diphenylbutanaMide;

Molecular Formula:C20H21N3O

Molecular Weight:319.4

Assay: ≥99.%

Packing: Export worthy packing

Material Safety Data Sheet: Available on request